StonvexLoading…
StonvexStonvexStonvexCore line items from CRM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $41.52B | $37.90B | $34.86B | $31.35B |
Operating Income | $8.33B | $7.21B | $5.01B | $1.03B |
Net Income | $7.46B | $6.20B | $4.14B | $208.00M |
EPS (Diluted) | $7.80 | $6.36 | $4.20 | $0.21 |
Total Assets | $112.31B | $102.93B | $99.82B | $98.85B |
Total Liabilities | $53.16B | $41.76B | $40.18B | $40.49B |
Cash & Equivalents | $7.33B | $8.85B | $8.47B | $7.02B |
Free Cash Flow OCF − CapEx | $14.40B | $12.43B | $9.50B | $6.31B |
Shares Outstanding | 929.00M | 962.00M | 971.00M | 981.00M |